Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on May 22, 2025
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
GlobeNewswire
·
May 22, 2025
Real-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointestinal pain and a 49.8% reduction in bloating over an 8-week period First-of-Its-Kind inFoods® IBS Feedback Platform: New real-time …
Bitget Lists BuildOn ($B) adding it to Spot Trading
Chainwire
·
May 22, 2025
Victoria, Seychelles, May 22nd, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of BuildOn, adding it to spot trading. BuildOn is built on A2A (Agent-to-Agent) architecture and automates the entire …
Bitget to Support STP (STPT) Token Swap and Rebranding to AWE Network (AWE)
Chainwire
·
May 22, 2025
Victoria, Seychelles, May 22nd, 2025, Chainwire Bitget, a leading global cryptocurrency exchange and Web3 company, announces its full support for the STP (STPT) token swap and rebranding initiative to AWE Network (AWE). This strategic move aligns with STP’ …
NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia
GlobeNewswire
·
May 22, 2025
NEWPORT BEACH, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced the completion of a Phase I strategic research …
Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025
GlobeNewswire
·
May 22, 2025
Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime cardiogenic shock Phase 3 program WARRINGTON, Pa., May …
Ocean Power Technologies Completes First Sea Trial for WAM-V®s at US Coast Guard Approved Test Site in New Jersey
GlobeNewswire
·
May 22, 2025
MONROE TOWNSHIP, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative, cost-effective, low-carbon and artificial intelligence maritime services that enable safer and …
Arqit Quantum Inc. Announces Financial Results for First Half of Fiscal Year 2025
GlobeNewswire
·
May 22, 2025
LONDON, May 22, 2025 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a global leader in quantum-safe encryption, announces financial results for the first half of fiscal year 2025. Consistent with management’s preliminary …
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June
GlobeNewswire
·
May 22, 2025
TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the removal of all conditions precedent, related to its …
LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
GlobeNewswire
·
May 22, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide), which includes …
Bridger Aerospace Secures Record 120 Day Task Orders for Four of its Super Scoopers
GlobeNewswire
·
May 22, 2025
BELGRADE, Mont., May 22, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today announced that is has …
Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01
GlobeNewswire
·
May 22, 2025
Generation of additional clinical data allows for a more comprehensive assessment of the full potential of EVX-01, while strengthening the already strong clinical data package Will provide insights into the durability of immune and clinical responses up to …
Nouryon releases 2024 Sustainability Report highlighting advances in sustainable solutions and environmental performance
GlobeNewswire
·
May 22, 2025
Nouryon, a global specialty chemicals leader, published its sixth annual sustainability report. The report provides an in-depth overview of the Company's progress and achievements over the past year, emphasizing its commitment to meet evolving customer …
Amphista Therapeutics showcases cryo-EM enabled platform for discovering novel Targeted Glue™ degraders at SLAS Europe 2025
GlobeNewswire
·
May 22, 2025
Innovative Eclipsys® platform enables rational design of novel Targeted Glues™ with superior drug-like properties Cambridge, UK, 22 May 2025 – Amphista Therapeutics, a leader in the discovery of next-generation, Targeted Protein Degradation (TPD) …
Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux
GlobeNewswire
·
May 22, 2025
Daix, May 22, 2025 Pursuant to Article 241-2 of the AMF General Regulations (Règlement Général de l’Autorité des marchés financiers), the purpose of this description is to present the objectives and terms of the Company’s share repurchase program approved …
Descriptif du Programme de Rachat d’Actions Pouvant Être Mis en Œuvre dans le Cadre du Contrat de Liquidité Conclu avec Kepler Chevreux
GlobeNewswire
·
May 22, 2025
Daix, le 22 mai 2025 En application de l'article 241-2 du Règlement Général de l’Autorité des marchés financiers (AMF), le présent descriptif a pour finalité de présenter les objectifs ainsi que les modalités du programme de rachat d’actions autorisé par l …
Sofwave to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
·
May 22, 2025
SAN CLEMENTE, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Assaf Korner, Chief …
Avalyn to Participate in the Jefferies Global Healthcare Conference in June
GlobeNewswire
·
May 22, 2025
CAMBRIDGE, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will participate in the …
Rhino Federated Computing Raises $15M Series A to Scale Federated AI Across Regulated Industries
GlobeNewswire
·
May 22, 2025
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Rhino Federated Computing, the leading platform for federated AI collaboration, today announced the close of an oversubscribed $15 million Series A funding round led by AlleyCorp. All existing institutional …
Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 22, 2025
NORWOOD, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and participate …
Jabra launches Engage AI Complete, the human-focused AI software for call centers
GlobeNewswire
·
May 22, 2025
Engage AI Complete is a new premium tier of its Engage AI software for call centers – uniquely analyzing not only what is said, but also how it is said, in real time, while also removing background noise. Engage AI Complete integrates generative AI and …